Prof. Dimitrios Karussis | Hadassah International

Hadassah and Neurogenesis Announce Groundbreaking Results From Phase 2 MS Study

A Phase 2 study at Hadassah Hospital Ein Kerem has revealed significant clinical improvements in patients with progressive multiple sclerosis (MS) after being treated with NG-01 stem cells developed by…

MS Research

Researchers at Hadassah Stop the Progression of Amyotrophic Lateral Sclerosis (ALS)

MS Research

Hadassah Conducts Unprecedented Trial of Stem Cell Treatment for MS

Stem Cell Research

New Hadassah Medical Center Clinical Trial Data Show Promise for Stem Cell Therapy in Treating ALS

ALS Research

FDA Approves Multi-Center US Clinical Trials to Treat ALS with Israel Stem Cell Technology

Stem Cell Research

BrainStorm Stem Cell Technology Administered at Hadassah Yields Major Therapeutic Results in Patient with ALS and Myasthenia Gravis

ALS Research

ALS Stem Cell Trial Yielding “Impressively Positive” Findings

MS Research

Hadassah Center for Multiple Sclerosis Holds its Annual Conference

ALS Research

Researchers at Hadassah ‬Stop the Progression of Amyotrophic Lateral Sclerosis (ALS)

ALS Research

Hadassah Clinical Trial Reveals Safety and Efficacy of Stem Cell Technology in Treating ALS

ALS Research

Hadassah’s Multiple Sclerosis Center: A Global Leader in Treating MS with Stem Cells

ALS Research

Clinical Trial Using Adult Stem Cell Therapy to Treat ALS Begins at Hadassah University Medical Center

ALS Research

Back on Course—by Wendy Elliman (as appeared in Hadassah Magazine, January 2009, Vol. 90 No. 5)

Stem Cell Research

Hadassah “Stars” Recognized For Stem Cell Advances

ALS Research

Hadassah International

Hadassah and Neurogenesis Announce Groundbreaking Results From Phase 2 MS Study

Hadassah and Neurogenesis Announce Groundbreaking Results From Phase 2 MS Study

The Search for a Miracle Cure for MS

Malia’s 18-year Odyssey with MS–and Back to Life As She Knew It

Hadassah Shares Breakthroughs at Annual World Stem Cell Summit

Hadassah’s Prof. Karussis Will Chair International Neuroimmunology Conference

Researchers at Hadassah Stop the Progression of Amyotrophic Lateral Sclerosis (ALS)

Hadassah Conducts Unprecedented Trial of Stem Cell Treatment for MS

New Hadassah Medical Center Clinical Trial Data Show Promise for Stem Cell Therapy in Treating ALS

FDA Approves Multi-Center US Clinical Trials to Treat ALS with Israel Stem Cell Technology

BrainStorm Stem Cell Technology Administered at Hadassah Yields Major Therapeutic Results in Patient with ALS and Myasthenia Gravis

ALS Stem Cell Trial Yielding “Impressively Positive” Findings

Hadassah Center for Multiple Sclerosis Holds its Annual Conference

Researchers at Hadassah ‬Stop the Progression of Amyotrophic Lateral Sclerosis (ALS)

Hadassah Clinical Trial Reveals Safety and Efficacy of Stem Cell Technology in Treating ALS

Hadassah’s Multiple Sclerosis Center: A Global Leader in Treating MS with Stem Cells

Clinical Trial Using Adult Stem Cell Therapy to Treat ALS Begins at Hadassah University Medical Center

Back on Course—by Wendy Elliman (as appeared in Hadassah Magazine, January 2009, Vol. 90 No. 5)

Hadassah “Stars” Recognized For Stem Cell Advances

Hadassah Physicians Explore New Bone Marrow Treatment